Johnson & Johnson (NYSE: JNJ) said Tuesday that its second-quarter revenue was flat, as the company had to deal with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE